Home » Stocks » AXIM Biotechnologies

AXIM Biotechnologies, Inc. (AXIM)

Stock Price: $0.640 USD -0.010 (-1.57%)
Updated Oct 16, 2020 3:54 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 75.68M
Revenue (ttm) 696,474
Net Income (ttm) -4.41M
Shares Out 118.29M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 16, 2020
Last Price $0.640
Previous Close $0.650
Change ($) -0.010
Change (%) -1.57%
Day's Open 0.633
Day's Range 0.610 - 0.650
Day's Volume 80,997
52-Week Range 0.1 - 1.44

More Stats

Market Cap 75.68M
Enterprise Value 80.27M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 118.29M
Float 71.43M
EPS (basic) -0.06
EPS (diluted) -0.06
FCF / Share -0.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta -0.82
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 108.66
PB Ratio 85.29
Revenue 696,474
Operating Income -4.88M
Net Income -4.41M
Free Cash Flow -4.99M
Net Cash -4.59M
Net Cash / Share -0.04
Gross Margin 27.99%
Operating Margin -700.47%
Profit Margin -632.80%
FCF Margin -716.06%
ROA -52.26%
ROE n/a
ROIC -68.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue0.800.200.050.050.05--0.040.01
Revenue Growth308.7%311.19%1.09%-4.23%---333.33%-
Gross Profit0.220.19--0.11---0.040.01
Operating Income-6.51-5.04-3.15-3.76-10.05-0.51--0.01-
Net Income-6.45-6.75-4.17-5.81-10.09-0.58-0.09-0.01-
Shares Outstanding61.9557.2853.3041.7337.0533.0033.0033.0023.28
Earnings Per Share-0.10-0.12-0.08-0.17-0.27-0.02---
Operating Cash Flow-5.02-4.85-3.08-1.29-1.54-0.34-0.030.02-
Capital Expenditures-----0.02----
Free Cash Flow-5.02-4.85-3.08-1.29-1.56-0.34-0.030.02-
Cash & Equivalents0.751.962.061.220.140.670.000.020.02
Total Debt5.065.876.401.771.521.050.050.05-
Net Cash / Debt-4.30-3.91-4.34-0.55-1.38-0.38-0.05-0.030.02
Assets1.692.092.191.451.260.740.060.130.14
Liabilities8.458.178.483.822.961.320.150.140.13
Book Value-6.76-6.08-6.28-2.37-1.70-0.58-0.09-0.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name AXIM Biotechnologies, Inc.
Country United States
Employees 3
CEO John W. Huemoeller

Stock Information

Ticker Symbol AXIM
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: AXIM

Description

AXIM Biotechnologies is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). The company's NeuCovix is the rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. It is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was founded in 2010 and is headquartered in San Diego, California.